Yüklüyor......
TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy
BACKGROUND: Before the advent of neoadjuvant chemotherapy, radiotherapy and surgery alone were associated with a high risk of uncontrolled locoregional relapses in locally advanced breast cancer (LABC). MATERIAL AND METHODS: In the 1990s we initiated two neoadjuvant protocols, where patients with LA...
Kaydedildi:
Yayımlandı: | Acta Oncol |
---|---|
Asıl Yazarlar: | , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Informa Healthcare
2014
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4245178/ https://ncbi.nlm.nih.gov/pubmed/24909504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/0284186X.2014.922215 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|